By selecting the Yes option, Leave Amgen.co.uk option, you understand that you are leaving the corporate page of Amgen UK and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Europe is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Europe. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
The "Next Generation Population Health" project is a collaborative effort between Hywel Dda University Health Board, Swansea Bay University Health Board, Swansea University, and Amgen, aimed at improving cardiovascular disease (CVD) risk prediction and prevention in Wales.
The project consists of two phases:
The initial feedback from the clinics, which aimed to optimise lipid and blood pressure control, was very positive, and the evaluation will continue until early 2025.
